Singapore biotherapeutics firm Hummingbird bags $125m in series C roundMay 18, 2021 | Funding The new capital will be used to develop precision therapeutics for the treatment of multiple myeloma. Source link How useful was this post? Click on a star to rate it! Submit Rating Average rating 0 / 5. Vote count: 0 No votes so far! Be the first to rate this post.